Literature DB >> 25483777

B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity.

Jason Qian1, Qiao Wang2, Marei Dose3, Nathanael Pruett1, Kyong-Rim Kieffer-Kwon1, Wolfgang Resch1, Genqing Liang1, Zhonghui Tang4, Ewy Mathé1, Christopher Benner5, Wendy Dubois6, Steevenson Nelson1, Laura Vian1, Thiago Y Oliveira2, Mila Jankovic2, Ofir Hakim7, Anna Gazumyan2, Rushad Pavri8, Parirokh Awasthi9, Bin Song10, Geng Liu10, Longyun Chen10, Shida Zhu10, Lionel Feigenbaum9, Louis Staudt11, Cornelis Murre12, Yijun Ruan4, Davide F Robbiani2, Qiang Pan-Hammarström13, Michel C Nussenzweig14, Rafael Casellas15.   

Abstract

The antibody gene mutator activation-induced cytidine deaminase (AID) promiscuously damages oncogenes, leading to chromosomal translocations and tumorigenesis. Why nonimmunoglobulin loci are susceptible to AID activity is unknown. Here, we study AID-mediated lesions in the context of nuclear architecture and the B cell regulome. We show that AID targets are not randomly distributed across the genome but are predominantly grouped within super-enhancers and regulatory clusters. Unexpectedly, in these domains, AID deaminates active promoters and eRNA(+) enhancers interconnected in some instances over megabases of linear chromatin. Using genome editing, we demonstrate that 3D-linked targets cooperate to recruit AID-mediated breaks. Furthermore, a comparison of hypermutation in mouse B cells, AID-induced kataegis in human lymphomas, and translocations in MEFs reveals that AID damages different genes in different cell types. Yet, in all cases, the targets are predominantly associated with topological complex, highly transcribed super-enhancers, demonstrating that these compartments are key mediators of AID recruitment.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25483777      PMCID: PMC4272762          DOI: 10.1016/j.cell.2014.11.013

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  59 in total

1.  Robust 4C-seq data analysis to screen for regulatory DNA interactions.

Authors:  Harmen J G van de Werken; Gilad Landan; Sjoerd J B Holwerda; Michael Hoichman; Petra Klous; Ran Chachik; Erik Splinter; Christian Valdes-Quezada; Yuva Oz; Britta A M Bouwman; Marjon J A M Verstegen; Elzo de Wit; Amos Tanay; Wouter de Laat
Journal:  Nat Methods       Date:  2012-09-09       Impact factor: 28.547

2.  RPA accumulation during class switch recombination represents 5'-3' DNA-end resection during the S-G2/M phase of the cell cycle.

Authors:  Arito Yamane; Davide F Robbiani; Wolfgang Resch; Anne Bothmer; Hirotaka Nakahashi; Thiago Oliveira; Philipp C Rommel; Eric J Brown; Andre Nussenzweig; Michel C Nussenzweig; Rafael Casellas
Journal:  Cell Rep       Date:  2013-01-03       Impact factor: 9.423

Review 3.  Origin and pathogenesis of B cell lymphomas.

Authors:  Marc Seifert; René Scholtysik; Ralf Küppers
Journal:  Methods Mol Biol       Date:  2013

4.  Mouse model of endemic Burkitt translocations reveals the long-range boundaries of Ig-mediated oncogene deregulation.

Authors:  Alexander L Kovalchuk; Camilo Ansarah-Sobrinho; Ofir Hakim; Wolfgang Resch; Helena Tolarová; Wendy Dubois; Arito Yamane; Makiko Takizawa; Isaac Klein; Gordon L Hager; Herbert C Morse; Michael Potter; Michel C Nussenzweig; Rafael Casellas
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

5.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

6.  Master transcription factors and mediator establish super-enhancers at key cell identity genes.

Authors:  Warren A Whyte; David A Orlando; Denes Hnisz; Brian J Abraham; Charles Y Lin; Michael H Kagey; Peter B Rahl; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

Review 7.  The hierarchy of the 3D genome.

Authors:  Johan H Gibcus; Job Dekker
Journal:  Mol Cell       Date:  2013-03-07       Impact factor: 17.970

Review 8.  Mechanisms of programmed DNA lesions and genomic instability in the immune system.

Authors:  Frederick W Alt; Yu Zhang; Fei-Long Meng; Chunguang Guo; Bjoern Schwer
Journal:  Cell       Date:  2013-01-31       Impact factor: 41.582

9.  AID/APOBEC cytosine deaminase induces genome-wide kataegis.

Authors:  Artem G Lada; Alok Dhar; Robert J Boissy; Masayuki Hirano; Aleksandr A Rubel; Igor B Rogozin; Youri I Pavlov
Journal:  Biol Direct       Date:  2012-12-18       Impact factor: 4.540

10.  Global changes in the nuclear positioning of genes and intra- and interdomain genomic interactions that orchestrate B cell fate.

Authors:  Yin C Lin; Christopher Benner; Robert Mansson; Sven Heinz; Kazuko Miyazaki; Masaki Miyazaki; Vivek Chandra; Claudia Bossen; Christopher K Glass; Cornelis Murre
Journal:  Nat Immunol       Date:  2012-10-14       Impact factor: 25.606

View more
  133 in total

1.  Eradication of Central Nervous System Leukemia of T-Cell Origin with a Brain-Permeable LSD1 Inhibitor.

Authors:  Shiori Saito; Jiro Kikuchi; Daisuke Koyama; Shin Sato; Hiroo Koyama; Naoki Osada; Yoshiaki Kuroda; Koshi Akahane; Takeshi Inukai; Takashi Umehara; Yusuke Furukawa
Journal:  Clin Cancer Res       Date:  2018-12-05       Impact factor: 12.531

2.  Convergent BCL6 and lncRNA promoters demarcate the major breakpoint region for BCL6 translocations.

Authors:  Zhengfei Lu; Nicholas R Pannunzio; Harvey A Greisman; David Casero; Chintan Parekh; Michael R Lieber
Journal:  Blood       Date:  2015-08-14       Impact factor: 22.113

3.  Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma.

Authors:  S Hartmann; B Schuhmacher; T Rausch; L Fuller; C Döring; M Weniger; A Lollies; C Weiser; L Thurner; B Rengstl; U Brunnberg; M Vornanen; M Pfreundschuh; V Benes; R Küppers; S Newrzela; M-L Hansmann
Journal:  Leukemia       Date:  2015-12-10       Impact factor: 11.528

Review 4.  Lingering Questions about Enhancer RNA and Enhancer Transcription-Coupled Genomic Instability.

Authors:  Gerson Rothschild; Uttiya Basu
Journal:  Trends Genet       Date:  2017-01-10       Impact factor: 11.639

Review 5.  Ontogeny, Genetics, Molecular Biology, and Classification of B- and T-Cell Non-Hodgkin Lymphoma.

Authors:  Russell James Hubbard Ryan; Ryan Alan Wilcox
Journal:  Hematol Oncol Clin North Am       Date:  2019-05-18       Impact factor: 3.722

6.  CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity.

Authors:  Andreas Herrmann; Christoph Lahtz; Toshikage Nagao; Joo Y Song; Wing C Chan; Heehyoung Lee; Chanyu Yue; Thomas Look; Ronja Mülfarth; Wenzhao Li; Kurt Jenkins; John Williams; Lihua E Budde; Stephen Forman; Larry Kwak; Thomas Blankenstein; Hua Yu
Journal:  Cancer Res       Date:  2017-07-17       Impact factor: 12.701

7.  JH6 downstream intronic sequence is dispensable for RNA polymerase II accumulation and somatic hypermutation of the variable gene in Ramos cells.

Authors:  Diana P Castiblanco; Darrell D Norton; Robert W Maul; Patricia J Gearhart
Journal:  Mol Immunol       Date:  2018-04-04       Impact factor: 4.407

8.  Suppression by TFR cells leads to durable and selective inhibition of B cell effector function.

Authors:  Peter T Sage; Noga Ron-Harel; Vikram R Juneja; Debattama R Sen; Seth Maleri; Waradon Sungnak; Vijay K Kuchroo; W Nicholas Haining; Nicolas Chevrier; Marcia Haigis; Arlene H Sharpe
Journal:  Nat Immunol       Date:  2016-10-03       Impact factor: 25.606

9.  Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma.

Authors:  Weicheng Ren; Xiaofei Ye; Hong Su; Wei Li; Dongbing Liu; Mohammad Pirmoradian; Xianhuo Wang; Bo Zhang; Qiang Zhang; Longyun Chen; Man Nie; Yao Liu; Bin Meng; Huiqiang Huang; Wenqi Jiang; Yixin Zeng; Wenyu Li; Kui Wu; Yong Hou; Klas G Wiman; Zhiming Li; Huilai Zhang; Roujun Peng; Shida Zhu; Qiang Pan-Hammarström
Journal:  Blood       Date:  2018-03-15       Impact factor: 22.113

10.  AID and TET2 co-operation modulates FANCA expression by active demethylation in diffuse large B cell lymphoma.

Authors:  J Jiao; Y Jin; M Zheng; H Zhang; M Yuan; Z Lv; W Odhiambo; X Yu; P Zhang; C Li; Y Ma; Y Ji
Journal:  Clin Exp Immunol       Date:  2018-11-13       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.